ACAD
31.96
+1.59
+5.24%
AEMD
0.215
+0.005
+2.1429%
APRI
1.91
-0.01
-0.78%
ARNA
4.33
-0.01
-0.23%
ATEC
1.4
0.00
0.00%
CNAT
7.75
+0.99
+14.64%
CRXM
0.195
+0.002
+1.1837%
CYTX
1.19
+0.01
+0.85%
DXCM
60.16
+1.79
+3.07%
GNMK
13.29
+0.2
+1.53%
HALO
13.93
+0.62
+4.66%
ILMN
187.17
+2.8
+1.52%
INNV
0.13
-0.019
-12.8600%
INO
8.285
+0.195
+2.410%
ISCO
0.061
+0.003
+6.087%
ISIS
63.37
+2.22
+3.63%
LGND
72.95
+2.65
+3.77%
LPTN
2.48
-0.04
-1.59%
MBVX
1.62
-0.13
-7.43%
MEIP
1.74
-0.09
-4.92%
MNOV
3.55
+0.23
+6.93%
MRTX
28.42
+2.05
+7.77%
MSTX
0.499
-0.021
-4.038%
NBIX
38.78
+1.45
+3.88%
NUVA
44.6
+0.62
+1.41%
ONCS
0.35
+0.01
+3.40%
ONVO
3.66
-0.27
-6.87%
OREX
7.54
+0.29
+4.00%
OTIC
34.23
+0.47
+1.39%
QDEL
27.15
+0.63
+2.38%
RCPT
147.43
+8.44
+6.07%
RGLS
16.82
+0.26
+1.57%
RMD
71.55
+1.3
+1.85%
SCIE
0.031
0.00
0.00%
SPHS
0.59
+0.05
+9.2407%
SRNE
12.29
+0.44
+3.71%
TROV
7
+0.23
+3.40%
VICL
0.923
+0.068
+7.9181%
VOLC
17.99
0.00
0.00%
ZGNX
1.34
+0.03
+2.29%
ACAD
31.96
+1.59
+5.24%
AEMD
0.215
+0.005
+2.1429%
APRI
1.91
-0.01
-0.78%
ARNA
4.33
-0.01
-0.23%
ATEC
1.4
0.00
0.00%
CNAT
7.75
+0.99
+14.64%
CRXM
0.195
+0.002
+1.1837%
CYTX
1.19
+0.01
+0.85%
DXCM
60.16
+1.79
+3.07%
GNMK
13.29
+0.2
+1.53%
HALO
13.93
+0.62
+4.66%
ILMN
187.17
+2.8
+1.52%
INNV
0.13
-0.019
-12.8600%
INO
8.285
+0.195
+2.410%
ISCO
0.061
+0.003
+6.087%
ISIS
63.37
+2.22
+3.63%
LGND
72.95
+2.65
+3.77%
LPTN
2.48
-0.04
-1.59%
MBVX
1.62
-0.13
-7.43%
MEIP
1.74
-0.09
-4.92%
MNOV
3.55
+0.23
+6.93%
MRTX
28.42
+2.05
+7.77%
MSTX
0.499
-0.021
-4.038%
NBIX
38.78
+1.45
+3.88%
NUVA
44.6
+0.62
+1.41%
ONCS
0.35
+0.01
+3.40%
ONVO
3.66
-0.27
-6.87%
OREX
7.54
+0.29
+4.00%
OTIC
34.23
+0.47
+1.39%
QDEL
27.15
+0.63
+2.38%
RCPT
147.43
+8.44
+6.07%
RGLS
16.82
+0.26
+1.57%
RMD
71.55
+1.3
+1.85%
SCIE
0.031
0.00
0.00%
SPHS
0.59
+0.05
+9.2407%
SRNE
12.29
+0.44
+3.71%
TROV
7
+0.23
+3.40%
VICL
0.923
+0.068
+7.9181%
VOLC
17.99
0.00
0.00%
ZGNX
1.34
+0.03
+2.29%
Home » Archive by Category

Xconomy

Finistere Raises $150M for New Fund Focused on Agricultural Biotech

March 2, 2015 – 11:01 am

Finistere Ventures, a San Diego investment firm focused on agricultural biotechnology, said it has closed on $150 million for its second fund. In a regulatory filing, the firm indicates plans to…

[[Click headline to continue reading.]]

Cancer Immunotherapy Companies: Looking Forward and Looking Back

March 2, 2015 – 1:00 am

I’ve been researching one of our local immunotherapy developers here in Seattle, trying to round up the views of industry experts regarding the future prospects of a drug at the front of its…

[[Click headline to continue reading.]]

West Coast Biotech Roundup: Flexus, NGM, Illumina, Bob Klein & More

February 26, 2015 – 12:25 pm

A few West Coast companies made news back east this week at the Advances in Genome Biology and Technology conference in Florida, while others (Flexus Biosciences, NGM Biotherapeutics) stayed home to…

[[Click headline to continue reading.]]

Shire Acquires Meritage Pharma in Deal Potentially Worth $245M

February 24, 2015 – 10:01 am

[Updated 2/24/15 6:10 pm. See below.] After acquiring ViroPharma last year in a $4.2 billion deal focused on Cinryze, the Irish pharmaceutical giant Shire says it is following through on a…

[[Click headline to continue reading.]]

Cebix Shuts Down Following Mid-Stage Trial of C-Peptide Drug

February 23, 2015 – 5:40 am

San Diego-based Cebix, which raised about $50 million to advance a C-peptide replacement therapy for treating diabetes-related microvascular problems, has quietly folded its tent. Jacob Fuchs, an…

[[Click headline to continue reading.]]

Innovation Hub: Meet the Science Evangelist

February 20, 2015 – 12:58 pm

Ainissa Ramirez says she’s a “Science Evangelist,” and she travels the country to preach her gospel in classrooms. As a result, the former Yale professor hopes to invigorate…

[[Click headline to continue reading.]]

WHO Approves 15-Minute Ebola Test Developed by Corgenix

February 20, 2015 – 11:38 am

Doctors who continue to battle the Ebola epidemic that rages on in Africa—even if it’s once again out of the headlines in the U.S.—might be getting a new tool thanks to Corgenix, a…

[[Click headline to continue reading.]]

WHO Approves 15-Minute Ebola Test Developed by Corgenix

February 20, 2015 – 11:38 am

Doctors who continue to battle the Ebola epidemic that rages on in Africa—even if it’s once again out of the headlines in the U.S.—might be getting a new tool thanks to Corgenix, a…

[[Click headline to continue reading.]]

Seragon CEO Rich Heyman Is Going on Hiatus

February 19, 2015 – 10:01 pm

The moving boxes are stacked in the hallways of San Diego’s Seragon Pharmaceuticals, and that means the end is near for CEO Rich Heyman. He’s fine with that. As Heyman put it, “I’m not going to go…

[[Click headline to continue reading.]]

West Coast Biotech Roundup: Laguna, SeaGen, Unchained, DME & More

February 19, 2015 – 1:29 pm

We’ve grouped our items according to topic this week. First come the financings, led by the relocated Laguna Pharma in San Diego. Then comes the clinical and regulatory news, which is topped by…

[[Click headline to continue reading.]]